Copy to clipboard 
Exactech has formed a new leadership structure. Jeffrey R. Binder, Exactech’s Chairman of the Board, has been appointed Chief Executive Officer of the company. Darin Johnson will continue in the role of President. The changes, which are effective immediately, bring additional depth and expertise to Exactech’s executive leadership team to position the company for continued growth. Both will remain on Exactech’s board of directors.
Mr. Binder joined Exactech’s board in 2018. He is a 30-year veteran of the medical device and diagnostics industry. Most notably in orthopedics, Mr. Binder was President and CEO of Biomet. He led the company for eight years before it was acquired by Zimmer for $13 billion. As CEO of Exactech, he will work closely with Mr. Johnson and the executive leadership team to drive overall business strategy and introduce new innovations in clinical care.
Mr. Johnson was appointed President and Chief Executive Officer in 2020 following the retirement of Mr. David Petty. Mr. Johnson has been with the company since 2002 and previously served as Senior Vice President of Extremities, which included leading the Equinoxe® shoulder line.
In his capacity as President, Mr. Johnson will oversee the company’s business units, as well as its Human Resources and Information Technologies functions.
“Following the disruption caused by the COVID-19 pandemic, the orthopaedics market is on strong footing and ripe for solutions that help surgeons improve patients’ lives,” Mr. Binder said. “Today’s leadership changes will better position Exactech to address this demand. It’s a privilege to assume the role of CEO, and I’m excited to work with Darin and team, the board and our partners at TPG [Capital] to further Exactech’s market leadership.”
“Over the past several years, we have continued to strengthen our position as the innovation leader in shoulder while expanding our product and technology platforms through important product launches across our businesses,” Mr. Johnson said. “Throughout my nearly two decades at the company, I have seen this organization evolve, innovate, and grow, always in the pursuit of benefiting our employees and physician partners, as well as the patients we serve. I look forward to working with Jeff and the team to capitalize on the opportunities ahead.”
Exactech has recently launched several new products. Earlier in March, Exactech announced the issuance of a patent for its Newton™ Knee, and at AAOS, the company featured several new products, technologies and upcoming launches, including the Laser Cage Glenoid, Predict+ and Humeral Augmented Tray, as well as the Spartan Hip Stem, a next-generation direct anterior hybrid stem.
Source: Exactech
Exactech has formed a new leadership structure. Jeffrey R. Binder, Exactech’s Chairman of the Board, has been appointed Chief Executive Officer of the company. Darin Johnson will continue in the role of President. The changes, which are effective immediately, bring additional depth and expertise to Exactech’s executive leadership team to position...
Exactech has formed a new leadership structure. Jeffrey R. Binder, Exactech’s Chairman of the Board, has been appointed Chief Executive Officer of the company. Darin Johnson will continue in the role of President. The changes, which are effective immediately, bring additional depth and expertise to Exactech’s executive leadership team to position the company for continued growth. Both will remain on Exactech’s board of directors.
Mr. Binder joined Exactech’s board in 2018. He is a 30-year veteran of the medical device and diagnostics industry. Most notably in orthopedics, Mr. Binder was President and CEO of Biomet. He led the company for eight years before it was acquired by Zimmer for $13 billion. As CEO of Exactech, he will work closely with Mr. Johnson and the executive leadership team to drive overall business strategy and introduce new innovations in clinical care.
Mr. Johnson was appointed President and Chief Executive Officer in 2020 following the retirement of Mr. David Petty. Mr. Johnson has been with the company since 2002 and previously served as Senior Vice President of Extremities, which included leading the Equinoxe® shoulder line.
In his capacity as President, Mr. Johnson will oversee the company’s business units, as well as its Human Resources and Information Technologies functions.
“Following the disruption caused by the COVID-19 pandemic, the orthopaedics market is on strong footing and ripe for solutions that help surgeons improve patients’ lives,” Mr. Binder said. “Today’s leadership changes will better position Exactech to address this demand. It’s a privilege to assume the role of CEO, and I’m excited to work with Darin and team, the board and our partners at TPG [Capital] to further Exactech’s market leadership.”
“Over the past several years, we have continued to strengthen our position as the innovation leader in shoulder while expanding our product and technology platforms through important product launches across our businesses,” Mr. Johnson said. “Throughout my nearly two decades at the company, I have seen this organization evolve, innovate, and grow, always in the pursuit of benefiting our employees and physician partners, as well as the patients we serve. I look forward to working with Jeff and the team to capitalize on the opportunities ahead.”
Exactech has recently launched several new products. Earlier in March, Exactech announced the issuance of a patent for its Newton™ Knee, and at AAOS, the company featured several new products, technologies and upcoming launches, including the Laser Cage Glenoid, Predict+ and Humeral Augmented Tray, as well as the Spartan Hip Stem, a next-generation direct anterior hybrid stem.
Source: Exactech
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
